About Med2Go

Med2Go is a private limited company (BV/SRL) based in Liège, founded in 2025. Its main activity is classified as "Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten". For the 2025 financial year, Med2Go reported a loss of €79,483. Revenue was not published, which is common for abbreviated accounts. The gross margin came to -€78,759. Equity is negative (-€77,983): liabilities exceed assets.

Juridical situation
Normal situation
Company number
1024.797.179
Founding date
Founded on 27-06-2025
EUID number
BEKBOBCE.1024.797.179
Type of enterprise
Rechtspersoon
Location
Esplanade De L'europe 2 Liège 4020
Juridical form
BV — Private limited company (BV/SRL)
Signals
Negative equity
Reporting losses
Poor liquidity
Negative cashflow
Negative EBITDA

Financial ratios

Profit
€ -79K
Equity
€ -78K
Gross margin
€ -79K
Health
Solvability > 25%
-196.5%
Liquidity > 1.0
0.31
Profitability > 0%
101.9%
2025
Gross margin
€ -79K
EBITDA
€ -79K
Profit
€ -79K
Equity
€ -78K
Solvability
-196.49%
Debt
€ 118K
Cash
€ 34

Frequently asked questions

Answers to the most common questions about Med2Go, based on official government data and the filed annual accounts.

What is the VAT number of Med2Go?

The VAT number of Med2Go is BE1024.797.179.

When was Med2Go established?

Med2Go was founded in 27-06-2025.

What is the official address of Med2Go?

The official address of Med2Go is Esplanade De L'europe 2 Liège 4020.

What is the legal form of Med2Go?

The juridical form of Med2Go is Private limited company (BV/SRL).

What is the annual revenue of Med2Go?

The 2025 accounts of Med2Go do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.

Is Med2Go a reliable company?

Med2Go is a registered Rechtspersoon with company number 1024.797.179 and can be verified through the official CBE database.

What is the credit limit of Med2Go?

The estimated credit limit of Med2Go is €0.

Is Med2Go still active?

Med2Go currently has the status "Normal situation" and is active.

Further reading

View all insights

Sources